UNSPSC 51413702: Fronepidil

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94JPL25DUK. European Medicines Agency schedules Fronepidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07816MIG. Fronepidil generally arises in the molecular formula C21H31NO2.

UNSPSC 51413702 Fronepidil is a Commodity code tracking individual pharmaceutical products supplied to state and local emergency responders, health agencies, and cooperative purchasing alliances. State and local governments procure under this code to stock emergency medications, pharmacy benefit programs, and multi-jurisdictional drug distribution networks. The scope spans sealed-bid purchases of specific medication line items for fire rescue operations, direct-to-manufacturer prescription programs serving state employee health plans, and generic pharmaceutical contracts distributed through authorized wholesalers to multiple public facilities. Issuing bodies include municipal purchasing departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance administering on behalf of member state and local government facilities).

Recent activity concentrates in Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications on April 24, 2026, with response deadline April 8, 2026, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and SLBE set-aside eligibility. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 posted January 20, 2026, with response deadline March 26, 2026, to establish multistate contracts for generic pharmaceuticals and OTC products effective July 1, 2026, distributed through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC to participating state and local facilities in Minnesota and Oregon.